Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Materials Science & Engineering. C, Materials for Biological Applications
|
November 26, 2013
Novel ether-linkages containing aliphatic copolyesters of poly(butylene 1,4-cyclohexanedicarboxylate) as promising candidates for biomedical applications
Matteo Gigli, Nadia Lotti, Marco Vercellino, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
April 16, 2025
Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy
Luca Prosperini, Lorenzo Pradelli, Laura Santoni, et al.
Journal of Neuropathology and Experimental Neurology
|
December 2, 2005
Grey matter pathology in multiple sclerosis
Marco Vercellino, Federica Plano, Barbara Votta, et al.
Multiple Sclerosis and Related Disorders
|
April 14, 2023
SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study
Marco Vercellino, Chiara Bosa, Anastasia Alteno, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 25, 2022
Impact of COVID-19 lockdown on progressive multiple sclerosis patients
Marco Vercellino, Chiara Bosa, Anastasia Alteno, et al.
Journal of Clinical Epidemiology
|
August 6, 2002
Validity of hospital morbidity records for amyotrophic lateral sclerosis. A population-based study
Adriano Chiò, Giovannino Ciccone, Andrea Calvo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 1, 2018
Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation
Maria Teresa Giordana, Paola Cavalla, Antonio Uccelli, et al.
The International Journal of Artificial Organs
|
October 16, 2012
An overview of the methodological approach to the in vitro study of anti-infective biomaterials
Davide Campoccia, Ilaria Cangini, Laura Selan, et al.
Frontiers in Neurology
|
November 8, 2021
Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series
Stefania F De Mercanti, Marco Vercellino, Chiara Bosa, et al.
Scientific Reports
|
September 15, 2015
Electro-magnetic field promotes osteogenic differentiation of BM-hMSCs through a selective action on Ca(2+)-related mechanisms
Loredana Petecchia, Francesca Sbrana, Roberto Utzeri, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Materials Science & Engineering. C, Materials for Biological Applications
|
November 26, 2013
Novel ether-linkages containing aliphatic copolyesters of poly(butylene 1,4-cyclohexanedicarboxylate) as promising candidates for biomedical applications
Matteo Gigli, Nadia Lotti, Marco Vercellino, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
April 16, 2025
Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy
Luca Prosperini, Lorenzo Pradelli, Laura Santoni, et al.
Journal of Neuropathology and Experimental Neurology
|
December 2, 2005
Grey matter pathology in multiple sclerosis
Marco Vercellino, Federica Plano, Barbara Votta, et al.
Multiple Sclerosis and Related Disorders
|
April 14, 2023
SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study
Marco Vercellino, Chiara Bosa, Anastasia Alteno, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 25, 2022
Impact of COVID-19 lockdown on progressive multiple sclerosis patients
Marco Vercellino, Chiara Bosa, Anastasia Alteno, et al.
Journal of Clinical Epidemiology
|
August 6, 2002
Validity of hospital morbidity records for amyotrophic lateral sclerosis. A population-based study
Adriano Chiò, Giovannino Ciccone, Andrea Calvo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 1, 2018
Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation
Maria Teresa Giordana, Paola Cavalla, Antonio Uccelli, et al.
The International Journal of Artificial Organs
|
October 16, 2012
An overview of the methodological approach to the in vitro study of anti-infective biomaterials
Davide Campoccia, Ilaria Cangini, Laura Selan, et al.
Frontiers in Neurology
|
November 8, 2021
Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series
Stefania F De Mercanti, Marco Vercellino, Chiara Bosa, et al.
Scientific Reports
|
September 15, 2015
Electro-magnetic field promotes osteogenic differentiation of BM-hMSCs through a selective action on Ca(2+)-related mechanisms
Loredana Petecchia, Francesca Sbrana, Roberto Utzeri, et al.
Page
of 5